1333153-86-8

Upstream product

• 149793-69-1 3-fluoro-5-trifluoromethyl-benzonitrile 
• 1333153-38-0 3-isopropoxy-5-(trifluoromethyl)benzamide 
• 1333153-39-1 3-isopropoxy-5-(trifluoromethyl)benzonitrile 
• 1333153-40-4 3-isopropoxy-5-(trifluoromethyl)benzothioamide 
• 1333153-41-5 methyl 3-isopropoxy-5-(trifluoromethyl)benzimidothioate 
• 1333153-42-6 3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazole 
• 1333151-91-9 isopropyl (Z)-3-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate 

Downstream Products

• 1333153-57-3 (isobutylcarbonic) (Z)-3-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic anhydride 
• 1333152-11-6 (Z)-pyridin-2-ylmethyl 3-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylate 
• 1333153-58-4 C₁₅H₁₅F₃N₄O₂ 
• 1333152-00-3 (Z)-3-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylonitrile 
• 1388841-41-5 (Z)-2-(2-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)vinyl)-1,3,4-oxadiazole 
• 1388842-03-2 (Z)-3-(3-(3-isopropoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylohydrazide 

Relevant academic research and scientific papers

METHODS OF PROMOTING WOUND HEALING USING CRM1 INHIBITORS

The invention generally relates to the use of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula (I) or a pharmaceutically acceptable salt thereof, wherein Ring A, X, R1, R

NUCLEAR TRANSPORT MODULATIORS AND USES THEREOF

The invention generally relates to the field of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to new substituted-heterocyclic azole compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g